Experience on Both Sides of the FDA Inspection Table

FD-AID was founded to give regulated organizations something difficult to obtain from conventional consulting: the combined judgment of an experienced FDA Investigator and a pharmaceutical Quality and Compliance executive.

DeVaughn Edwards

DeVaughn Edwards is the founder and Principal Consultant of FD-AID, LLC. He spent 14 years with the U.S. Food and Drug Administration, conducting and supporting inspections across more than 20 countries. His FDA work included sterile aseptic and terminally sterilized products, solid oral dosage forms, ointments, active pharmaceutical ingredients, biologics and biotechnology operations, clinical investigations, imports, and other regulated systems.

His inspections contributed to significant regulatory actions, including Warning Letters and injunction-related work, and his federal service included a Commissioner’s commendation. That experience taught him how Investigators build an inspectional record: what attracts attention, which inconsistencies trigger deeper document requests, how isolated observations become systemic concerns, and why some company responses fail to restore FDA confidence.

Pharmaceutical Leadership After FDA

After leaving FDA, DeVaughn spent approximately 13 years in senior pharmaceutical Quality and Compliance leadership. His experience includes work with Johnson & Johnson/McNeil during consent-decree remediation and the return of critical products to market, as well as senior responsibilities with Lonza and Hikma/West-Ward.

This second chapter provided an equally important perspective: the operational realities of correcting systems while manufacturing continues, managing commitments across functions, preparing executives and subject-matter experts, and creating sustainable changes that work after regulatory pressure subsides.

Why FD-AID Is Different

FD-AID does not approach compliance as a theoretical interpretation of regulations. Engagements connect regulatory requirements to manufacturing practice, laboratory evidence, management oversight, product risk, and the way FDA Investigators test whether a quality system is actually working.

An Extended Network of Experienced Specialists

FD-AID is a principal-led consultancy, not a volume consulting firm that assigns client work to whoever happens to be available. DeVaughn remains directly involved in each engagement and accountable for the regulatory strategy, quality of the work, and final deliverables.

When an engagement requires additional specialization or simultaneous workstreams, FD-AID can scale the team through an extended network of experienced independent consultants and technical specialists selected for the specific manufacturing, laboratory, clinical, data-integrity, or quality-system risk. Clients know who is assigned, why that expertise is needed, and who remains accountable for the result.

Global, Independent, and Direct

FD-AID serves clients in the United States and internationally. Depending on the scope, engagements may be performed on site, remotely, or through a blended approach. Clients work directly with experienced consultants selected for the regulatory and technical risk involved.